Oncolytics Biotech Stock Forward View - Accumulation Distribution
| ONCY Stock | USD 1.06 0.23 27.71% |
Oncolytics Stock outlook is based on your current time horizon.
At this time the rsi of Oncolytics Biotech's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.07) | EPS Estimate Current Year (0.36) | EPS Estimate Next Year (0.34) | Wall Street Target Price 5.5611 | EPS Estimate Current Quarter (0.07) |
Using Oncolytics Biotech hype-based prediction, you can estimate the value of Oncolytics Biotech from the perspective of Oncolytics Biotech response to recently generated media hype and the effects of current headlines on its competitors.
Oncolytics Relative Strength Index
Oncolytics Biotech Hype to Price Pattern
Investor biases related to Oncolytics Biotech's public news can be used to forecast risks associated with an investment in Oncolytics. The trend in average sentiment can be used to explain how an investor holding Oncolytics can time the market purely based on public headlines and social activities around Oncolytics Biotech. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Oncolytics Biotech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Oncolytics Biotech.
Oncolytics Biotech after-hype prediction price | USD 0.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oncolytics | Build AI portfolio with Oncolytics Stock |
Oncolytics Biotech Additional Predictive Modules
Most predictive techniques to examine Oncolytics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncolytics using various technical indicators. When you analyze Oncolytics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 36648.79 | 1.1 M |
| Check Oncolytics Biotech Volatility | Backtest Oncolytics Biotech | Information Ratio |
Oncolytics Biotech Trading Date Momentum
| On February 13 2026 Oncolytics Biotech was traded for 1.06 at the closing time. The top price for the day was 1.10 and the lowest listed price was 0.83 . The trading volume for the day was 4.7 M. The trading history from February 13, 2026 did not cause price change. The trading delta at closing time against the current closing price is 16.04% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Oncolytics Biotech to competition |
Other Forecasting Options for Oncolytics Biotech
For every potential investor in Oncolytics, whether a beginner or expert, Oncolytics Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncolytics Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncolytics. Basic forecasting techniques help filter out the noise by identifying Oncolytics Biotech's price trends.Oncolytics Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncolytics Biotech stock to make a market-neutral strategy. Peer analysis of Oncolytics Biotech could also be used in its relative valuation, which is a method of valuing Oncolytics Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oncolytics Biotech Market Strength Events
Market strength indicators help investors to evaluate how Oncolytics Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncolytics Biotech shares will generate the highest return on investment. By undertsting and applying Oncolytics Biotech stock market strength indicators, traders can identify Oncolytics Biotech entry and exit signals to maximize returns.
| Accumulation Distribution | 1.1 M | |||
| Daily Balance Of Power | 0.8519 | |||
| Rate Of Daily Change | 1.28 | |||
| Day Median Price | 0.97 | |||
| Day Typical Price | 1.0 | |||
| Price Action Indicator | 0.21 | |||
| Period Momentum Indicator | 0.23 |
Oncolytics Biotech Risk Indicators
The analysis of Oncolytics Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncolytics Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncolytics stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.15 | |||
| Semi Deviation | 4.37 | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.82 | |||
| Downside Variance | 22.22 | |||
| Semi Variance | 19.06 | |||
| Expected Short fall | (5.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Oncolytics Biotech
The number of cover stories for Oncolytics Biotech depends on current market conditions and Oncolytics Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oncolytics Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oncolytics Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Oncolytics Biotech Short Properties
Oncolytics Biotech's future price predictability will typically decrease when Oncolytics Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oncolytics Biotech often depends not only on the future outlook of the potential Oncolytics Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncolytics Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 76.5 M | |
| Cash And Short Term Investments | 15.9 M |
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.